116 related articles for article (PubMed ID: 10941806)
1. Changes of CD4/CD8 ratio and interleukin-16 in systemic lupus erythematosus.
Matsushita M; Hayashi T; Ando S; Sekigawa I; Iida N; Hashimoto H; Hirose S
Clin Rheumatol; 2000; 19(4):270-4. PubMed ID: 10941806
[TBL] [Abstract][Full Text] [Related]
2. Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus.
Maeda N; Sekigawa I; Iida N; Matsumoto M; Hashimoto H; Hirose S
Scand J Rheumatol; 1999; 28(3):166-70. PubMed ID: 10380839
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating HLA-DR+ CD4+ T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy.
Raziuddin S; Nur MA; al-Wabel AA
Scand J Immunol; 1990 Feb; 31(2):139-45. PubMed ID: 2137939
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
Hingorani M; Calder VL; Buckley RJ; Lightman S
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
[TBL] [Abstract][Full Text] [Related]
5. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
6. A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE.
Sekigawa I; Matsushita M; Lee S; Maeda N; Ogasawara H; Kaneko H; Iida N; Hashimoto H
Autoimmunity; 2000; 33(1):37-44. PubMed ID: 11204252
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
[TBL] [Abstract][Full Text] [Related]
8. Relationship between CD4(+)/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16.
Koike M; Sekigawa I; Okada M; Matsumoto M; Iida N; Hashimoto H; Oshimi K
Leuk Res; 2002 Aug; 26(8):705-11. PubMed ID: 12191564
[TBL] [Abstract][Full Text] [Related]
9. Relationship between T lymphocyte subsets and cortisol in systemic lupus erythematosus.
Shah D; Kiran R; Wanchu A; Bhatnagar A
Kathmandu Univ Med J (KUMJ); 2009; 7(27):213-9. PubMed ID: 20071865
[TBL] [Abstract][Full Text] [Related]
10. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions.
Raziuddin S; Danial HB; Kelley M
Clin Immunol Immunopathol; 1988 Jul; 48(1):42-9. PubMed ID: 3260161
[TBL] [Abstract][Full Text] [Related]
11. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
12. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of cyclosporine microemulsion in patients with corticosteroid-resistant systemic lupus erythematosus.
Wada Y; Kotani T; Takeuchi T; Wakura R; Wakura D; Makino S; Hanafusa T
Mod Rheumatol; 2015 Sep; 25(5):708-13. PubMed ID: 25835315
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
15. Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus.
Linker-Israeli M; Gray JD; Quismorio FP; Horwitz DA
Clin Exp Immunol; 1988 Aug; 73(2):236-41. PubMed ID: 2972425
[TBL] [Abstract][Full Text] [Related]
16. [Coexpression of CD4 and CD8 antigens and the appearance of HLA-DR and CD25 receptors on lymphocytes as markers of immune activation in patients with HIV infection].
Radkowski M; Sadowska M; Kopicz-Kamińska E; Horban A; Slusarczyk J
Pol Merkur Lekarski; 1996 Nov; 1(5):325-6. PubMed ID: 9273207
[TBL] [Abstract][Full Text] [Related]
17. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.
Engler JB; Undeutsch R; Kloke L; Rosenberger S; Backhaus M; Schneider U; Egerer K; Dragun D; Hofmann J; Huscher D; Burmester GR; Humrich JY; Enghard P; Riemekasten G
Ann Rheum Dis; 2011 Dec; 70(12):2176-83. PubMed ID: 21926188
[TBL] [Abstract][Full Text] [Related]
18. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
19. Two distinct subsets of patients with systemic lupus erythematosus.
McInerney MF; Clough JD; Senitzer D; Cathcart MK
Clin Immunol Immunopathol; 1988 Oct; 49(1):116-32. PubMed ID: 2970355
[TBL] [Abstract][Full Text] [Related]
20. Diminished expression of CD59 on activated CD8+ T cells undergoing apoptosis in systemic lupus erythematosus and Sjögren's syndrome.
Tsunoda S; Kawano M; Koni I; Kasahara Y; Yachie A; Miyawaki T; Seki H
Scand J Immunol; 2000 Mar; 51(3):293-9. PubMed ID: 10736099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
